期刊文献+

脑胶质瘤易感基因PLA2G4C的短串联重复序列多态性的初步研究

Study on the polymorphysims of the susceptibility gene PLA2G4C in patients with glioma
原文传递
导出
摘要 目的运用分子生物学方法筛查脑胶质瘤易感基因PLA2G4C的短串联重复序列的多态性,并进一步确定这些多态性与脑胶质瘤发病的关系。方法以天坛医院为主收集入院脑胶质瘤病人和对照组的血液及肿瘤组织,对肿瘤和血液标本分别进行DNA提取,对基因PLA2G4C的特定片段进行PCR扩增,利用变性高效液相色谱及琼脂糖凝胶电泳等技术进行比较研究,推测突变的意义。结果本组共收集标本223份,通过琼脂糖凝胶电泳检测到了短串联重复序列,通过变性高效液相色谱技术检测到了纯合峰及杂合峰。结论PLA2G4C的短串联重复序列多态性与胶质瘤的发病有一定关系,并可通过血液标本进行此多态性的筛查。DHPLC是一种高效、经济、简便可靠的基因多态性的筛选方法。 Objective To screen the polymorphysims of glioma relative gene PLA2G4C with molecular-biological methods and find the relationship between the polymorphysims and pathogenesis of glioma. Methods The blood and glioma samples were mainly collected from the patients in Tiantan hospital. DNA was extracted from these samples and several special fragments of tumor relative genes such as PLA2G4C were amplified by PCR. Agarose gel eleetrophoresis and DHPLC were used to screen gene polymorphysim. Results This study included 223 blood samples. Short tendem repeats were found by Agarose gel. Heterogenous and homogenous peak were found in PLA2G4C gene with the method of DHPLC. Conclusions Short Tandem Repeat in PLA2G4C gene, which can be screened from blood samples, relates to the pathogenesis of glioma. DHPLC in combination with direct sequencing is an effective, economical and reliable method to screen gene polymorphism.
出处 《中华神经外科杂志》 CSCD 北大核心 2007年第4期309-312,共4页 Chinese Journal of Neurosurgery
基金 北京市科委重大项目资助(H020920030130)
关键词 神经胶质瘤 基因 多态性 Gliomas Gene Polymorphism
  • 相关文献

参考文献14

二级参考文献54

  • 1李美华,朱贤立,赵洪洋.星形细胞肿瘤PCNA、p53蛋白表达与细胞增殖和肿瘤预后[J].中国临床神经外科杂志,2000,5(z1):43-44. 被引量:2
  • 2张福林.胶质瘤WHO新分类的分子遗传学基础[J].中国神经肿瘤杂志,2003,1(4):193-199. 被引量:6
  • 3Kleihues P, Cavenee WK. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000.1-109.
  • 4Ichimura K, Ohgaki H, Kleihues P, et al. Molecular pathogenesis of astrocytic tumors. J Neuro-Oncol, 2004, 70:137-160.
  • 5Jeuken JWM, yon Deimling A, Wesseling P. Molecular pathogenesis of oligodendroglial tumors. J Neuro-Oncol, 2004, 70:161-181.
  • 6Bian XW, Du LL, Shi JQ, et al. Correlation of bFGF, FGFR and VEGF expression with vascularity and malignancy of human astrocytomas. Analyt Quant Cytol Histol, 2000,22:267-274.
  • 7Hirashima M, Bernstein A, Stanford WL, et al. Gene-trap expression screening to identify endothelial-specific genes. Blood,2004, 104:711-718.
  • 8Zhou Y, Bian XW, Gong WH, et al. Activation of formylpeptide receptor (FPR) in malignant astrocytoma cells promotes the production of vascular endothelial growth factor (VEGF). FASEB J,2003, 17 :A1346.
  • 9Bian XW, Chen JH, Jiang XF, et al. Angiogenesis as an immunopharmacologic target in inflammation and cancer. Int Immunopharmacol, 2004,4:1537-1547.
  • 10Verheul HMW, Voest EE, Schlingemann RO. Are tumours angiogenesis-dependent? J Pathol, 2004, 202:5-13.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部